In this Healthed lecture, Dr Adam Nelson explains that weight loss should now be considered a therapeutic target in the same way we treat cholesterol and blood pressure when implementing secondary prevention after a heart attack for instance. Dr Nelson will also present evidence for the effectiveness of GLP-1 agonists in this space and how agents such as semaglutide can and should be included in clinical care according to international cardiology guidelines and even our own TGA recommendations.

<p>In this Healthed lecture, Dr Adam Nelson explains that weight loss should now be considered a therapeutic target in the same way we treat cholesterol and blood pressure when implementing secondary prevention after a heart attack for instance. Dr Nelson will also present evidence for the effectiveness of GLP-1 agonists in this space and how agents such as semaglutide can and should be included in clinical care according to international cardiology guidelines and even our own TGA recommendations.</p>

Healthed's medical education channel features the latest high quality clinical interviews and lectures from leading experts in their field, offering health professionals a convenient new way to boost their knowledge.

Advertisement